Showing results (61-70 of 88) with videos related to
Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly)V Ballova, J-U Rüffer, H Haverkamp, et al.The Review of Scientific Instruments|April 5, 2017
Fast piezoelectric valve offering controlled gas injection in magnetically confined fusion plasmas for diagnostic and fuelling purposesM Griener, O Schmitz, K Bald, et al.Blood|September 16, 2011
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphomaBoris Böll, Henning Bredenfeld, Helen Görgen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2021
PET-Based Staging Is Cost-Effective in Early-Stage Follicular LymphomaAndrea C Lo, Lyndon P James, Anca Prica, et al.Physical Review Letters|October 28, 2022
Quasicontinuous Exhaust Scenario for a Fusion Reactor: The Renaissance of Small Edge Localized ModesG F Harrer, M Faitsch, L Radovanovic, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2012
Dose-intensification in early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD14 trialBastian von Tresckow, Annette Plütschow, Michael Fuchs, et al.Physical Review Letters|June 28, 2011
First observation of edge localized modes mitigation with resonant and nonresonant magnetic perturbations in ASDEX UpgradeW Suttrop, T Eich, J C Fuchs, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2024
Correlation between progression-free and overall survival in patients with Hodgkin lymphoma: a comprehensive analysis of individual patient data from randomized German Hodgkin Study Group (GHSG) trialsP J Bröckelmann, H Müller, M Fuchs, et al.The Oncologist|March 29, 2020
Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II TrialsGabriele Reinartz, Caroline Molavi Tabrizi, Ruediger Liersch, et al.Blood|September 2, 2008
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphomaCarsten Kobe, Markus Dietlein, Jeremy Franklin, et al.Pageof 9